Treatment of cancer in sub-Saharan Africa

The Lancet Oncology

Volumn 14, Issue 4, 2013, Pages

  Kingham, T Peter ^a   Alatise, Olusegun I ^b   Vanderpuye, Verna ^c   Casper, Corey ^d   Abantanga, Francis A ^e   Kamara, Thaim B ^f   Olopade, Olufunmilayo I ^g   Habeebu, Muhammad ^h   Abdulkareem, Fatimah B ^h   Denny, Lynette ⁱ  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c KORLE BU TEACHING HOSPITAL   (Ghana)

^d UNIVERSITY OF WASHINGTON   (United States)

^e KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^f UNIVERSITY OF SIERRA LEONE   (Sierra Leone)

^g UNIVERSITY OF CHICAGO   (United States)

^h UNIVERSITY OF LAGOS   (Nigeria)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BICALUTAMIDE; CAPECITABINE; CYCLOPHOSPHAMIDE; DIETHYLSTILBESTROL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; FLUTAMIDE; IRINOTECAN; OXALIPLATIN; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN; VIRUS DNA; WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ALCOHOLISM; ANDROGEN DEPRIVATION THERAPY; BREAST CANCER; BURKITT LYMPHOMA; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DNA DETERMINATION; DRUG COST; ECHOGRAPHY; EPSTEIN BARR VIRUS INFECTION; ESOPHAGUS CANCER; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYSTERECTOMY; KAPOSI SARCOMA; LAPAROSCOPY; LIVER CELL CARCINOMA; LUNG METASTASIS; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MASTECTOMY; MEDICAL EXPERT; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NEPHROBLASTOMA; NONHODGKIN LYMPHOMA; ONCOLOGIST; ORCHIECTOMY; OVARIECTOMY; PAPILLOMAVIRUS INFECTION; PATHOLOGIST; PATIENT CARE; PATIENT SAFETY; PERSONNEL SHORTAGE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH PROBLEM; RADIATION ONCOLOGIST; RETINOBLASTOMA; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKING; STOMACH CANCER; STOMACH SURGERY; SURVIVAL TIME; THORAX RADIOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS IDENTIFICATION; WART VIRUS;

AFRICA SOUTH OF THE SAHARA; HEALTH PERSONNEL; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; NEOPLASMS; PALLIATIVE CARE; POVERTY; PUBLIC HEALTH;

EID: 84875796210     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70472-2     Document Type: Review

References (83)

1. Parkin DM, Bray FI, Devesa SS Cancer burden in the year 2000. The global picture. Eur J Cancer 2001, 37(suppl 8):S4-66.
2. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
4. Burkitt D A "tumour safari" in east and central Africa. Br J Cancer 1962, 16:379-386.
5. Farmer PE, Kim JY Surgery and global health: a view from beyond the OR. World J Surg 2008, 32:533-536.
6. Umoh NJ, Lesi OA, Mendy M, et al. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver Int 2011, 31:215-221.
7. Adewuyi SA, Arogundade R, Igashi JB, Chom ND, Hamidu AU, Campbell OB The pattern of chest radiographs findings in metastatic cancer patients seen in a tertiary hospital in northern Nigeria. Niger Postgrad Med J 2011, 18:245-250.
8. Marjerrison S, Fernandez CV, Price VE, Njume E, Hesseling P The use of ultrasound in endemic Burkitt lymphoma in Cameroon. Pediatr Blood Cancer 2012, 58:352-355.
9. Gonzaga MA How accurate is ultrasound in evaluating palpable breast masses?. Pan Afr Med J 2010, 7:1.
10. Adesina A, Chumba D, Nelson AM, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol 2013, 14:e152-e157.
11. Ojo BA, Buhari MO, Malami SA, Abdulrahaman MB Surgical lymph node biopsies in University of Ilorin Teaching Hospital, Ilorin, Nigeria. Niger Postgrad Med J 2005, 12:299-304.
12. Ajape AA, Ibrahim KO, Fakeye JA, Abiola OO An overview of cancer of the prostate diagnosis and management in Nigeria: the experience in a Nigerian tertiary hospital. Ann Afr Med 2010, 9:113-117.
13. Klufio GO A review of genitourinary cancers at the Korle-Bu teaching hospital Accra, Ghana. West Afr J Med 2004, 23:131-134.
14. Siegel R, Desantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012, 62:220-241.
15. Ahmed M Prostate cancer diagnosis in a resource-poor setting: the changing role of digital rectal examination. Trop Doct 2011, 41:141-143.
16. Dawam D, Rafindadi AH, Kalayi GD Benign prostatic hyperplasia and prostate carcinoma in native Africans. BJU Int 2000, 85:1074-1077.
17. Bowa K An overview of the diagnosis and management of prostate cancer in Nigeria: experience from a north-central state of Nigeria. Ann Afr Med 2010, 9:111-112.
18. Magoha GA Subcapsular orchidectomy in the management of prostatic carcinoma in Nigerians. East Afr Med J 1989, 66:400-403.
19. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 2004, 109:418-424.
20. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database Syst Rev 2010, 1. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC), CD008285.
21. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet 2011, 113:14-24.
22. Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst 2010, 102:1557-1567.
23. Qiao Y-L, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008, 9:929-936.
24. Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA The severity, outcome and challenges of breast cancer in Nigeria. Breast 2006, 15:399-409.
25. Obaseki DE, Olu-Eddo AN, Ogunbiyi JO Diagnostic accuracy of fine needle aspiration cytology of palpable breast masses in Benin City, Nigeria. West Afr J Med 2010, 29:259-262.
26. Gakwaya A, Kigula-Mugambe JB, Kavuma A, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer 2008, 99:63-67.
27. Ukwenya AY, Yusufu LM, Nmadu PT, Garba ES, Ahmed A Delayed treatment of symptomatic breast cancer: the experience from Kaduna, Nigeria. S Afr J Surg 2008, 46:106-110.
28. Odigie VI, Tanaka R, Yusufu LM, et al. Psychosocial effects of mastectomy on married African women in Northwestern Nigeria. Psychooncology 2010, 19:893-897.
29. Anyanwu SN, Nwose P, Ihekwoaba E, Mbaeri AT, Chukwuanukwu TO Neoadjuvant chemotherapy for locally advanced premenopausal breast cancer in Nigerian women: early experience. Niger J Clin Pract 2010, 13:215-217.
30. Mieog JS, van der Hage JA, van de Velde CJ Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev 2007, 2. CD005002.
31. Arowolo OA, Akinkuolie AA, Lawal OO, Alatise OI, Salako AA, Adisa AO The impact of neoadjuvant chemotherapy on patients with locally advanced breast cancer in a Nigerian semiurban teaching hospital: a single-center descriptive study. World J Surg 2010, 34:1771-1778.
32. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009, 27:4515-4521.
33. Eniu A, Carlson RW, El Saghir NS, et al. Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer 2008, 113(suppl 8):2269-2281.
34. Umoh NJ, Lesi OA, Mendy M, et al. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver Int 2011, 31:215-221.
35. Ndububa DA, Ojo OS, Adeodu OO, et al. Primary hepatocellular carcinoma in Ile-Ife, Nigeria: a prospective study of 154 cases. Niger J Med 2001, 10:59-63.
36. Kachala R Systematic review: epidemiology of oesophageal cancer in sub-Saharan Africa. Malawi Med J 2010, 22:65-70.
37. Wu PC, Posner MC The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003, 4:481-488.
38. Mannell A, Murray W Oesophageal cancer in South Africa. A review of 1926 cases. Cancer 1989, 64:2604-2608.
39. Wentink MQ, Rakers M, Stupart DA, Algar U, Ramesar R, Goldberg PA Incidence and histological features of colorectal cancer in the Northern Cape Province, South Africa. S Afr J Surg 2010, 48:109-113.
40. SEER Cancer Statistics Review, 1975-2006 2009, National Cancer Institute, Bethesda, MD. M.J. Horner, L.A.G. Ries, M. Krapcho (Eds.).
41. Saidi H, Nyaim EO, Githaiga JW, Karuri D CRC surgery trends in Kenya, 1993-2005. World J Surg 2008, 32:217-223.
42. Dakubo JC, Naaeder SB, Tettey Y, Gyasi RK Colorectal carcinoma: an update of current trends in Accra. West Afr J Med 2010, 29:178-183.
43. Ota DM, Jacobs L, Kuvshinoff B Rectal cancer: the sphincter-sparing approach. Surg Clin North Am 2002, 82:983-993.
44. Desai Y, Coen LD, Barker EM Sphincter preservation for low rectal carcinoma-the Durban experience. S Afr J Surg 1995, 33:109-111.
45. Irabor D, Adedeji OA Colorectal cancer in Nigeria: 40 years on. A review. Eur J Cancer Care 2009, 18:110-115.
46. Rahman GA Rectal cancer: pattern and outcome of management in University of Ilorin Teaching Hospital, Ilorin, Nigeria. Ann Afr Med 2010, 9:164-169.
47. Adekunle OO, Ajao GO Colorectal cancer in adolescent Nigerians. Scand J Gastroenterol Suppl 1986, 124:183-186.
48. Aghaji MA, Obiekwe OM Sexual function in males following abdomino-perineal resection in Nigeria. Cent Afr J Med 1991, 37:301-303.
49. Rahman GA, Braimoh KT Preoperative staging of rectal carcinoma using transrectal ultrasonography (Trus): experience with 30 Nigerians. Niger Postgrad Med J 2007, 14:226-230.
50. Mandong BM, Manasseh AN, Tanko MN, Echejoh GO, Madaki AJ Epidemiology of gastric cancer in Jos University Teaching Hospital Jos a 20 year review of cases. Niger J Med 2010, 19:451-454.
51. Asombang AW, Kelly P Gastric cancer in Africa: what do we know about incidence and risk factors?. Trans R Soc Trop Med Hyg 2012, 106:69-74.
52. Ndububa DA, Agbakwuru EA, Olasode BJ, Aladegbaiye AO, Adekanle O, Arigbabu AO Correlation between endoscopic suspicion of gastric cancer and histology in Nigerian patients with dyspepsia. Trop Gastroenterol 2007, 28:69-71.
53. Afuwape OO, Irabor DO, Ladipo JK, Ayandipo B A review of the current profile of gastric cancer presentation in the university college hospital Ibadan, a tertiary health care institution in the tropics. J Gastrointest Cancer 2012, 43:177-180.
54. Osime OC, Momoh MI, Irowa OO, Obumse A Gastric carcinoma-a big challenge in a poor economy. J Gastrointest Cancer 2010, 41:101-106.
55. Ahmed AA The surgical management and outcome of oesophageal cancer in Addis Ababa. Ethiop Med J 2000, 38:147-152.
56. Ahmed A, Ukwenya AY, Makama JG, Mohammad I Management and outcome of gastric carcinoma in Zaria, Nigeria. Afr Health Sci 2011, 11:353-361.
57. Meredith P Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003, 25:2875-2890.
58. Israëls T, van de Wetering MD, Hesseling P, van Geloven N, Caron HN, Molyneux EM Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi. Pediatr Blood Cancer 2009, 53:47-52.
59. Abdel-Wahab M, Bourque J-M, Pynda Y, et al. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol 2013, 14:e168-e175.
60. Barton MB, Frommer M, Shafiq J Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 2006, 7:584-595.
61. Olasinde TA, Olugbemiro AA Over and under exposures of radiotherapy patients at the A B U Teaching Hospital, Zaria, Nigeria: case reports. Nig Q J Hosp Med 2011, 21:145-148.
62. Baatjes KJ, Apffelstaedt JP 7-year follow up of intra-operative radiotherapy for early breast cancer in a developing country. Breast 2012, 21:326-329.
63. Comprehensive audits of radiotherapy practices: a tool for quality improvement 2007, Quality Assurance Team for Radiation Oncology (QUATRO), International Atomic Energy Agency, Vienna.
64. Hadley LG, Rouma BS, Saad-Eldin Y Challenge of pediatric oncology in Africa. Semin Pediatr Surg 2012, 21:136-141.
65. Margaron FC, Poenaru D, Northcutt A Pediatric cancer spectrum in Kenya: a histopathologic review. Pediatr Surg Int 2010, 26:789-794.
66. Moreira C, Nachef MN, Ziamati S, et al. Treatment of nephroblastoma in Africa: results of the first French African pediatric oncology group (GFAOP) study. Pediatr Blood Cancer 2012, 58:37-42.
67. Mosam A, Shaik F, Uldrick TS, et al. The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and chemotherapy in treatment-naive patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa. Infect Agents Cancer 2010, 5(suppl 1):A80.
68. Casper C The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med 2011, 62:157-170.
69. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide 2010, International Agency for Research on Cancer, Lyon.
70. Ulrickson M, Press OW, Casper C Epidemiology, diagnosis, and treatment of HIV-associated non-Hodgkin lymphoma in resource-limited settings. Adv Hematol 2012, 2012:932658.
71. Scheffler RM, Liu JX, Kinfu Y, Dal Poz MR Forecasting the global shortage of physicians: an economic- and needs-based approach. Bull World Health Organ 2008, 86:516-523B.
72. Kingham TP, Kamara TB, Cherian MN, et al. Quantifying surgical capacity in Sierra Leone: a guide for improving surgical care. Arch Surg 2009, 144:122-127.
73. Groen RS, Samai M, Stewart K-A, et al. Untreated surgical conditions in Sierra Leone: a cluster randomised, cross-sectional, countrywide survey. Lancet 2012, 380:1082-1087.
74. Palmer-Wickham S, Beattie K, Boudreau A, Fitch M Schering Plough Lecture 2009. The twinning experience: meaning of an educational program for nurses in Kenya. Can Oncol Nurs J 2010, 20:129-142.
75. Wadler BM, Judge CM, Prout M, Allen JD, Geller AC Improving breast cancer control via the use of community health workers in South Africa: a critical review. J Oncol 2011, 2011:150423.
76. Steyn M, Muller A Traditional healers and cancer prevention. Curationis 2000, 23:4-11.
77. NCCN member institution brings American cancer clinic and training facility to Africa through USAID grant. NCCN eBulletin Newsletter (Fort Washington, PA) (accessed June 22, 2012). http://www.nccn.org/about/news/ebulletin/2009-11-09/africa.asp.
78. Knaul FM, Frenk J, Shulman L Closing the cancer divide: a blueprint to expand access in low and middle income countries 2011, for the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, Harvard Global Equity Initiative, Boston, MA.
79. Schwentner L, Wolters R, Wischnewsky M, Kreienberg R, Wockel A Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. Breast 2012, 21:171-177.
80. Kerr DJ, Midgley R Can we treat cancer for a dollar a day? Guidelines for low-income countries. N Engl J Med 2010, 363:801-803.
81. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011, 12:387-398.
82. Azim HA, Jazieh A-R, Jahanzeb M Editorial: the Abu Dhabi Declaration: why the hustle?. J Natl Compr Canc Netw 2010, 8(suppl 3):S2-S4.
83. Abdulrahman GOJ, Rahman GA Epidemiology of breast cancer in Europe and Africa. J Cancer Epidemiol 2012, 2012:915610.